Interview with Daniel Ghozzi, Managing Director UCB CIS, UCB Russia/CIS
What were the difficulties in the CIS regions around the time of the financial crisis? Were there similarities to the situation in Russia? Yes, the situation in the CIS was…
Address: Shabolovka str. 10 Building 2, floor 3 RUS – 119048 Moscow,Russia
Tel: +7 495 644 3322
Web: http://www.ucb.com/
UCB, headquartered in Brussels, Belgium, is a global biopharma company with a team of over 8500 talented employees, a strong market presence in more than 40 countries, € 3.2 billion in revenue (2010) and numerous strategic partnerships across the industry.
UCB operates in Russia and 11 CIS countries. It’s main office is in Moscow, Russia.
UCB’s medicines are making a real difference to the lives of people all over the world. Some of our products are among the leaders in their field
Epilepsy
Parkinson’s disease
Restless Legs Syndrome
Crohn’s disease
Rheumatoid arthritis
Allergies
Respiratory disease
Regulating cerebral functions
Attention Deficit Hyperactivity Disorder (ADHD)
What were the difficulties in the CIS regions around the time of the financial crisis? Were there similarities to the situation in Russia? Yes, the situation in the CIS was…
Last time Focus Reports met with you in 2006, the Russian pharmaceutical industry had enjoyed five straight years of growth. This growth has since continued through 2011. Can you provide…
There is a long history of trade between Russia and Britain. The Chamber of Commerce started in 1916. Can you outline how the organisation has evolved and its current role…
When the Russian Federation emerged from the former USSR in 1991 all the structures of the past social net that provided for the complete healthcare needs of citizens were…
See our Cookie Privacy Policy Here